Epidemiological data
Both groups had a similar average age of 60.5±14 in males and 61.6±17
years old in females. While 42.7% of males suffered from ICM with LVEF
≤35%, only 26.4% of females suffered from ICM who received WCD.
Following our data, the Israeli-ICD registry showed comparable
epidemiological frequency regarding gender differences. The average age
in both genders was similar, 64±14 in females and 64±13 in male
participants. In addition, ICM was significantly more observed in males
as compared to the female group (79% vs. 46%). On the other hand, more
women suffered from dilated cardiomyopathy (DCM) in comparison to men’s
participants (38% vs. 18%) [17]. In the VEST trial, the device
group consisted of 72.8% male participants with the percutaneous
coronary intervention (PCI) during the index hospitalization [8].
Males have a higher propensity for developing coronary heart disease as
well as ICM [18]. To summarize, our multicenter data corresponds
with previously published ICD data.